← Fulgent Genetics, Inc. FLGT
Market Price
$18.56
Market Cap
$528.54M
P/E Ratio
N/A
Revenue (FY 2025)
↑13.8% YoY
$322.67M
3-Yr CAGR: -19.5%
Net Income
↓-41.7% YoY
-$60.51M
Net Margin: -18.8%
Free Cash Flow
↓-545.1% YoY
-$124.21M
FCF Yield: -23.50%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity
Efficiency
-5.4%
ROA: -11.0%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (FLGT)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $18.3M | — | $11.6M | $-5.3M | — | — | — | $4.4M | $0.6M | — |
| FY 2017 | $18.7M | +2.5% | $10.2M | $-2.5M | +53.1% | — | — | $1.3M | $-1.6M | -353.5% |
| FY 2018 | $21.4M | +14.0% | $10.7M | $-5.6M | -123.4% | — | — | $-0.7M | $-3.0M | -91.6% |
| FY 2019 | $32.5M | +52.3% | $18.4M | $-0.4M | +92.7% | — | — | $5.5M | $4.3M | +244.6% |
| FY 2020 | $421.7M | +1,196.5% | $331.9M | $214.3M | +52,243.6% | — | — | $140.6M | $105.5M | +2,333.6% |
| FY 2021 | $992.6M | +135.4% | $777.1M | $507.4M | +136.7% | — | — | $538.6M | $514.8M | +387.9% |
| FY 2022 | $619.0M | -37.6% | $366.9M | $143.4M | -71.7% | — | — | $253.5M | $234.7M | -54.4% |
| FY 2023 | $289.2M | -53.3% | $104.5M | $-167.8M | -217.0% | — | — | $27.0M | $4.8M | -98.0% |
| FY 2024 | $283.5M | -2.0% | $107.2M | $-42.7M | +74.6% | — | — | $21.1M | $-19.3M | -501.5% |
| FY 2025 | $322.7M | +13.8% | $130.9M | $-60.5M | -41.7% | — | — | $-101.6M | $-124.2M | -545.1% |
Valuation
Market Price
$18.56
Market Cap
$528.54M
Enterprise Value
N/A
P/E Ratio
N/A
P/B Ratio
0.47
FCF Yield
-23.50%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
40.56%
Operating Margin
-28.23%
Net Margin
-18.75%
Return on Equity (ROE)
-5.44%
Return on Assets (ROA)
-10.99%
Asset Turnover
0.59x
Revenue 3-Yr CAGR
-19.52%
Financial Health & Liquidity
Current Ratio
16.16
Cash Ratio
1.47
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$50.19M
Total Debt
N/A
Book Value / Share
$39.15
Cash Flow Efficiency
Operating Cash Flow
-$101.64M
Capital Expenditures (CapEx)
$22.57M
Free Cash Flow
-$124.21M
OCF / Revenue
-31.50%
FCF / Revenue
-38.49%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
N/A
EPS (Basic)
N/A
Dividends / Share
N/A
Book Value / Share
$39.15
EPS YoY Growth
N/A
Balance Sheet (FY 2025)
Total Assets
$550.49M
Total Liabilities
$34.06M
Stockholders' Equity
$1.11B
Current Assets
$550.49M
Current Liabilities
$34.06M